Bariatric surgery and the kidneys

Česká verzia

Authors: M. Fried
Authors place of work: Klinické centrum ISCARE-Lighthouse, Praha a 1. lékařská fakulta UK Praha, přednosta prof. MUDr. Martin Fried, CSc.
Published in the journal: Vnitř Lék 2008; 54(5): 468-471
Category:

Summary

Overweight and obesity are connected with increased risk of obesity related co-morbidities, such as T2DM, hypertension, cardiovascular diseases, dyslipidaemia and others, as well as in higher risk of some malignant diseases. In obese population there is 2.5-3.3 fold increased risk of renal cell carcinoma in comparison with non-obese population of similar age. It has been proven in many studies that for severely obese patients there is no other more effective treatment of their obesity and co-morbidities than bariatric. Bariatric surgery decreases mortality risks, treat existing, obesity related co-morbidities, and can act as prevention of onset of new obesity related co-morbidities. Moreover at the end bariatric surgery lowers economic burden of health care systems. Nowadays, bariatric surgery is considered to be standard treatment option and pathway in complex management of morbidly obese patients.

Key words:
obesity - bariatric surgery - type 2 diabetes - renal malignancies

Zdroje

1. Obesity: Preventing and Managing the Global Epidemic. Report of a WHO consultation. Technical Report Series, No 894. Geneva 2000.

2. James WPT, Rigby N, Leach R. The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Cardiovasc Prev Rehabil 2004; 11: 3-8.

3. Haslam DW, James WPT. Obesity. Lancet 2005; 366: 1197-1209.

4. Chan JM, Rim EB, Colditz GA et al. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994; 17: 961-969.

5. Colditz GA, Willett WC, Rotnitzky A et al. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Int Med 1995; 122: 481-486.

6. Banegas JR, Polez-Garcia E, Gutierrez-Fisac JL et al. A simple estimate of mortality attributable to excess weight in the European Union. Eur J Clin Nutr 2003; 57: 201-208.

7. Adams KF, Schatzkin A, Hartus TB et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. New Engl J Med 2006; 355: 763-768.

8. Drenick EJ, Bale GS, Seltzer F et al. Excessive mortality and cause of death in morbidly obese men. JAMA 1980; 243: 443-444.

9. Srikanth SM et al. Renal cell carcinoma rollowing bariatric surgery. Obes Surg 2005; 15: 1165-1170.

10. Jong PE et al. Obesity and target organ damage: the kidney. Int J Obes 2002; 26: S21-S24.

11. Meier-Kriesche HU et al. The effect of BMI on long-term renal allograft survival. Transplantation 1999; 68: 1294-1297.

12. Halme L et al. Is obesity still a risk factor in renal transplantation? Transpl Int 1997; 10: 284-288.

13. Sawyer RG et al. Increased early morbidity and mortality with acceptable long-term function in severely obese patients undergoing liver transplantation. Clin Transplant 1999; 13: 126-130.

14. Buchwald H. Bariatric surgery for morbid obesity: health implications for patients, health professionals, and third-party payers. J Am Coll Surg 2005; 200: 593-604.

15. Buchwald H, Avidor Y, Braunwald E et al. Bariatric surgery: A systematic review and meta-analysis. JAMA 2004; 292: 1724-1737.

16. Svačina Š et al. Trendy soudobé diabetologie, sv 10. Praha: Galén 2005: 169-211.

17. Fried M, Pešková M, Kasalický M. New Approach in Surgical Treatment of Morbid Obesity: Laparoscopic Gastric Banding. Obes Surg 1995; 5: 74-76.

18. Fried M. Moderní chirurgické metody léčby obezity. Praha: Grada 2005.

19. Fried M, Hainer V, Basdevant A et al. Interdisciplinary European Guidelines on Surgery of Severe Obesity. Int J Obes 2007; 31: 569-577.

20. Fried M, Hainer V, Basdevant A et al. Interdisciplinary European Guidelines for Surgery for Severe (Morbid) Obesity. Obes Surg 2007; 70: 260-270.